Oxytocin Injection 5 I. U/1ml / High Quality

• Customization: Available
• Packaging From: 5 Ampoules/Box
• Packaging: Customization
• Model NO.: injection
• Dosage: Ready
• Transport Package: Shipping
• Specification: 1ml/ 5 I. U
• Trademark: brand
• Origin: China

Product Description

Value-added services:
 1) Packaging design by our team
 2) Registration service by our team
 3) Registration dossier available by our team
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Oxytocin Injection 5 I.U./1mL

Composition:

Each 1mL ampoule contains:

• Oxytocin - 5 International Units (I.U.)
• Excipients: Sodium chloride, Acetic acid (for pH adjustment), Water for injection

Description:

Oxytocin is a synthetic hormone identical to the natural oxytocin produced by the posterior pituitary gland. It stimulates uterine contractions and is used in obstetric care.

Indications:

Oxytocin Injection is indicated for:

• Induction and augmentation of labor in cases of inadequate uterine contractions
• Management of postpartum hemorrhage (PPH) due to uterine atony
• Prevention of postpartum uterine bleeding
• Facilitation of incomplete or missed abortion (miscarriage management)

Dosage & Administration:

For Labor Induction/Augmentation:

• Intravenous (IV) infusion:
  • Initial dose: 1-2 milliunits/min, increased gradually by 1-2 milliunits/min every 15-30 minutes
  • Maximum dose: 20 milliunits/min
  • Discontinue if hyperstimulation or fetal distress occurs

For Postpartum Hemorrhage (PPH) Prevention & Treatment:

• Intramuscular (IM): 5-10 I.U. after delivery of the placenta
• IV infusion: 10-40 I.U. diluted in 500-1000mL of saline or dextrose, infused at an appropriate rate

For Incomplete/Missed Abortion:

• IV infusion: 10 I.U. in 500mL normal saline or dextrose, infused at a rate of 20-40 drops per minute

Contraindications:

• Hypersensitivity to Oxytocin
• Hypertonic or hyperactive uterus
• Fetal distress when vaginal delivery is not imminent
• Obstructed labor (e.g., cephalopelvic disproportion, malpresentation)
• Uterine rupture risk (previous C-section, uterine surgery)

Precautions:

• Continuous fetal and maternal monitoring required during administration
• Avoid excessive doses to prevent uterine rupture or fetal distress
• Use cautiously in hypertensive patients or those with cardiovascular disease

Adverse Reactions:

• Maternal:
  • Uterine hyperstimulation (tetanic contractions, rupture risk)
  • Hypotension, tachycardia, nausea, vomiting
  • Fluid retention (risk of water intoxication)
• Fetal:
  • Bradycardia, distress, neonatal jaundice

Drug Interactions:

• Prostaglandins: Increased uterine effects (risk of hyperstimulation)
• Vasoconstrictors (e.g., epinephrine): May cause severe hypertension
• Anesthetic agents: May reduce oxytocin response

Overdose & Management:

• Symptoms: Uterine hyperstimulation, fetal distress, water intoxication
• Treatment: Discontinue oxytocin, administer supportive care (oxygen, fluids), consider tocolytic agents (e.g., terbutaline) if needed

Storage Conditions:

• Store at 2°C-8°C (Refrigerated)
• Do not freeze
• Protect from light